chrisvoncsefalvay/vaers-outcomes huggingface dataset:
He got his vaccine, he had no reactions.  The next morning he woke up his arm was sore, and it was that was for 2 days.  Then his breathing starting getting worse.  He started coughing, couldn't lay down, could not sleep due to that.  He went to the ER and they told him that there was nothing wrong and that it was just allergies.  They told him to go home and take some OTC cold medicine and that everything would be okay.  A week later he went to another ER for the same thing as he continued not to be able to breath, they did a bunch of tests and said that nothing was wrong and that it was just a call.  He then went to Hospital ER and they released him stating it had just a cold.  He then called his cardiologist and they told him to go back to Hospital, was admitted on 5/11/21 and they did more tests and said that he had a blood clot in his left lung and said that it had nothing to do with the vaccine.   He was discharged on 5/13/21.  They put him on Heparin while in the hospital and sent him home as a disgruntled patient.   They also told him that he had fluid around his heart and gave him medicine to get that taken away.  They sent him home on Lasix and Eliquis.  He then went to another hospital on Friday 5/14/21 as he was going crazy about the blood clot and went there and was kept there for 3 days and discharged on 5/16/21 with the same medications, Lasix and Eliquis.   He was also told that he had fluid around his heart again.  Before the vaccine he was very healthy, and was able to jog around his neighborhood and now he's not able to do so, and they told him that he was now having heart failure and is having trouble breathing because his heart is swelling up.  He went to see his cardiologist last Friday and that's when she told him about his heart failure.    ADMISSIONS:  ADMITTED 5/11/21 TO 5/13/21; 5/14/21 to 5/16/21.
Patient received a Janssen (J&J) Covid vaccine but is only 17 years old. This vaccine is indicated for 18 years and older right now. Patient wrote they were 18 on consent form. After receiving the vaccine, it was discovered from the dob written that patient is only 17 years old. VAERs report was created for this vaccine.
Patient reports she had increasing pain in her arm over the course of the afternoon after the vaccine was administered and it became severe enough she did not want to use her arm that evening and she almost dropped a dish. The pain resolved by 3/22. No redness, swelling, bruising reported at the injection site. No generalized pain, fatigue or fever.
Numbness in the R sided of the head; Sensitive Jaw; Headache on the right side of the head; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Numbness in the R sided of the head), PAIN IN JAW (Sensitive Jaw) and HEADACHE (Headache on the right side of the head) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (Numbness in the R sided of the head), PAIN IN JAW (Sensitive Jaw) and HEADACHE (Headache on the right side of the head). At the time of the report, HYPOAESTHESIA (Numbness in the R sided of the head), PAIN IN JAW (Sensitive Jaw) and HEADACHE (Headache on the right side of the head) outcome was unknown.            No concomitant medications were reported.  No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-086002 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-086002:
Tinnitus.   Constant 24 hour a day tinnitus. The day of vaccine I went home and went to sleep.  The next day woke up with tinnitus and it has remained ever since the date of the second shot on 4/16/21.
Chills, fever, cough, shortness of breath, chest pain, tachycardia and wheezing
On 10/02/03, I received the flu vaccine around 1:30 pm. About 1.5 hours later, my right index finger started twitching around 3 pm (I have video). About 5 pm, I had weird sensations in both feet which lasted all night. While sleeping, I woke up around 4 am because my eyelids were rapidly twitching and I also had a nerve twitch in my left calf and right arm. I called my physician on 10/03 and when he called back, I explained what happened. He thinks the nurse hit a nerve and told me I could take Benadryl and if the symptoms got worse or started shooting down my legs to go to the ER. On 10/04, my symptoms had subsided except for occasional foot sensations. I spoke to Occupational Health and reported what happened to them.
Moderna vaccine EUA within 4 minutes i began to feel faint, heart started pounding ,immediate headache and was very shaky.  I was laid down, cold compress. It came in waves over a period of 20 minutes. I was given a few sips of water. When it did not resolve I was taken to the ER and given IV fluids.  The doctor said I had an adverse reaction to something in the vaccine. The chief of Infectious disease thought I had a vaso vagel response.  While I am nervous to get the second vaccine , I will go forward and get it..
Patient presented to ED with difficulty walking, falls, right sided chest pain, lower extremity edema,  generally felling unwell
copd; High blood pressure; High cholesterol; Covid; came down with covid; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 3 (booster), single, (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Chronic Bronchitis" (unspecified if ongoing), notes: I have had years of chronic Bronchitis. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant) with onset 29Dec2021, outcome "unknown", described as "Covid"; SUSPECTED COVID-19 (medically significant) with onset 29Dec2021, outcome "recovered", described as "came down with covid"; CHRONIC OBSTRUCTIVE PULMONARY DISEASE (non-serious), outcome "recovered", described as "copd"; BLOOD PRESSURE INCREASED (non-serious), outcome "recovered", described as "High blood pressure"; BLOOD CHOLESTEROL INCREASED (non-serious), outcome "recovered", described as "High cholesterol". The patient underwent the following laboratory tests and procedures: blood cholesterol: high; blood pressure measurement: high.  Clinical information: The patient came down with Covid 29Dec2021. The patient was fully vaccinated three shots at the age of 51. The patient believed patent had the Omicron variant. Patient was down for four days, but after that felt good. Patient do believe without the vaccine patient would have been in the ICU..  The lot number for bnt162b2 was not provided and will be requested during follow up.
I gave the 4th dose of DTaP too early. 3rd dose given 11/11/2014. I administered DTaP on 5/6/2015.
flu; Initial information was received on 08-Oct-2020 regarding an unsolicited valid non-serious social media case from a consumer via Social media.  This case involves patient (unknown demography) who had flu (influenza), while the patient received vaccine INFLUENZA VACCINE.  Medical history, medical treatment(s), concomitant medications, vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed non-serious had flu (influenza) (unknown latency) following the administration of INFLUENZA VACCINE.  Details of laboratory data were not reported.  It was not reported if the patient received any corrective treatment.  At the time of report, the outcome was unknown for the event.  There will be no information available on the batch number for this case.
Information has been received from a physician concerning a male patient who was vaccinated subcutaneously with a "single dose vial" of Zostavax (lot# 654604/1405F) on an unspecified date. It was reported that the patient was taking concomitant therapy, however, the specific medications are unspecified. Subsequently, two weeks post vaccination (on an unspecified date) the patient developed some chickenpox. The physician reported that the patient developed a full-blown break out of chickenpox 3 months post vaccination. Medical attention was sought and it was reported that the physician swabbed the pox and sent culture to a lab. The patient was referred to a dermatologist. The outcome was unspecified. No product quality complaint was involved. Additional information has been requested.
Bilateral arm discomfort swelling erythema lymphadenopathy - neck: difficulty swallowing.
12/18:  itchy but no rash, headache 12/19:  very itchy all over, headache  12/20: very itch including palms of hands.  Sore throat and swollen tongue with a canker sore type sore on the tongue developed.  Took a Claritin around 2 am.  It helped. 12/22:  less itching, continued headache , weird thick feeling sore tongue still.  Itching minor. 12/23:  a feeling that entire gastrointestinal tract is inflamed, a little blood on tp when wiping (unsual for me).  Still have normal temperature (96.8) 12/24:  a considerable amount of blood from morning spit of mucus.  Very little from blowing nose.  Concerning.  I feel a lot of heat in body and brain but still no elevated temperature.   12/25:  only a little blood in spit. Sore all over,
1. Hives, dermatographism, and pruritus severe enough that it interferes with sleep  2. Seen by Dr. and diagnosed with chronic spontaneous urticaria (12/21) 3. Have never had an history of urticaria, asthma, or allergies (aside from seasonal) 4.  Was prescribed montelukast which did not improve symptoms 5. Seen by Dr. and prescribed regimen of Zytrec TID (2/22) 6. Have been on a regimen of Zyrtec TID since February, if not taking this regimen urticaria, dermatographia, and pruritus persists 7. Have experienced weight gain (114->121lbs)  since starting this regimen and has impacted mental health; anxious about taking another dose of vaccine
Patient is employee's son.  Employee reported that he woke up at 3 a.m. c/o difficulty breathing, face and lips swollen.  They gave dose of Benadryl and he seemed comfortable.  Visit to Urgent Care in the morning, they administered a steroid shot.  By Thursday afternoon, unusual looking rash all over.  Visit 4/9/21 to PCP advising good possibility that it is delayed reaction to vaccine, since patient has not had anything different to eat or have contact with.
This spontaneous report was received from a pharmacist refers to a 71 years old male patient. The patient's medical history included stent put in, however did not know date or where stent was inserted. On 07-JAN-2012, the patient was vaccinated with ZOSTAVAX (lot# H017449; expiration date on 20-DEC-2013) subcutaneously. No other co-suspects were reported. Concomitant medications included blood pressure medication and cholesterol lowering medication. On 11-JAN-2013 (less than 6 days prior to outbreak), the patient visited his primary care physician and physician diagnosed patient with an active case of shingles. No treatment information was reported. No labs or diagnostics test were performed. The patient presented dermatome right side back to front. Follow-up information and questionnaire was received from the Physician. The patient's current conditions included sulfa allergy, penicillin allergy, E-MYCIN allergy, hypertension, coronary artery disease (CAD), dyslipidemia, prostatic melanoma and loss memory. Medical history included and chickenpox (5 or 6 years old). The dose of ZOSTAVAX was 0.65ml one dose. The concomitant medication included folic acid, metoprolol, simvastatin (manufacturer unknown) and NEXIUM, MAXALT. Past drug history included sulfa, penicillin (unknown) and E-MYCIN. On 10-JAN-2013, the patient developed rash which developed into shingles with spreading of rash and vesicles appearing. The body temperature was 98.3. VZVIP specimen was obtained from vesicle and papule. At the time of the report, the outcome of shingles was not recovered. The relatedness for shingles was unknown for ZOSTAVAX. Additional information has been requested.
pt recv vax & some time after vax exp severe urticaria, some resp wheezing or tightening;pt was seen by an allergist;
Information has been received from a physician concerning a female patient who on 30-SEP-2009 was vaccinated with a third dose of GARDASIL (Lot No. not provided). Concomitant therapy included unspecified "birth control". On approximately 27-OCT-2009, four weeks after receiving the third dose of GARDASIL, the patient experienced pain and a knot in her arm, near the injection site. The patient called the physician for medical attention. At the time of the report, the patient had not recovered. Follow up information has been received from the physician who indicated that the patient had not followed up with him so he did not believe "it had anything to do with her GARDASIL" vaccination. Additional information is not expected.
Fever: 103 F, dizziness, general achiness, headache x 2 days (+ injection site soreness), feeling better on day #3. Took Ibuprofen for symptoms, no other treatment.
Chronic tonsillitis, swollen adenoids and sinusitis. As a result, pt is now scheduled to have a tonsillectomy and adenoids removed, due to chronic illness. He is scheduled for these procedures in August, 2000.
flare up of gout; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "arthritis" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: GOUT (non-serious), outcome "unknown", described as "flare up of gout". Additional information: She wanted to know how to reschedule second appointment. She has a flare up of gout (severe form of arthritis). So she couldn't make it to her second appointment. Clarified she has had arthritis all her life.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
After receiving the second dose of the covid 19 vaccine, as I was walking to the elevator, my vision started to become blurred and I began to see stars. I walked over to a nearby chair and as I sat down it felt as if my throat was closing. I began sweating profusely and my whole body was flushed. My heart rate was tachycardic and my blood pressure was hypertensive when checked in the ED. When I got to the ED, my vitals were obtained like I described but my heart rate had slowed down by time I got there. A nurse passing by explained that my heart was tachycardia when he assessed me in the chair. The ED did an EKG of my heart that determined my heart rate was normal sinus rhythm in the 70s. They observed me for roughly an hour and let me go home. My discharge papers explain I had a vagal response.
pt recvd vax 28oct94,woke up 29oct w/ feet tingling,feeling asleep & heavy;stayed home for 1 wk; tingling in hands on & off but gone when started on tegretol by neurologist;
On 4/5/01 at 05:00, mother reports nausea and vomiting X 3 episodes, by 11:00 AM, face with fine prickly rash, blue color to face. Admitted to hospital from approx. 12:00 to 14:00. Mother reports that doctor stated it was "effects of immunization".  Annual follow up on 11/03/2003: "Follow up was attempted in 07/2002.  We were unable to locate the patient.  Please see attached info which was transmitted to VAERS on 08/09/2002.  Patient unknown to health department for any visits other than 1 visit of 04/14/2001.  Phone # disconnected.  Physiican retired."
(L) deltoid with 11.5cm x 13cm area of erythema.  Warm to touch, painful on palpation. Area blanches on palpation, sl erythematous no clearly demarcated edges.
I stopped the pills on morning Saturday 17Apr2021 and had a full (shorter than usual, but normal heavy flow x 2 days and then tapering off over next 3 days) period; Despite being on birth control and not missing any doses ''I'' got ''my'' period again on 14Apr2021.; After spotting for 3 days, ''I'' stopped the pills on morning; This is a spontaneous report from a contactable pharmacist, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 09Apr2021 at 13:15 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroid, obese. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and unknown if ongoing and birth control (MANUFACTURER UNKNOWN) was ongoing. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; EN6208) via an unspecified route of administration in the left arm on 18Mar 2021 at 12:15 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. The patient previously also received amoxicillin (MANUFACTURER UNKNOWN), for unknown indication from an unknown date and experienced drug allergy. The previous period of patient finished on 06Apr2021 and she only stopped active birth control and got her period once a quarter; despite being on birth control and not missing any doses she got her period again on 14Apr2021. After spotting for 3 days, the patient stopped the pills on morning Saturday on 17Apr2021 and had a full (shorter than usual, but normal heavy flow x 2 days and then tapering off over next 3 days) period, and restarted birth control on Mon 19Apr2021. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were not taken as a result of reported events. The clinical outcome of the events despite being on birth control and not missing any doses she got her period again on an unknown date in Apr2021 and stopped the pills on morning Saturday 17Apr2021, spotting for 3 days was recovered on 17Apr2021 and had a full (shorter than usual, but normal heavy flow x 2 days and then tapering off over next 3 days) period was recovered on 19Apr2021.  No follow-up attempts are needed. No further information is expected.
excessive bleeding immediately the needle was withdrawn. then 9 hrs later when the bandage was being removed patient fainted for 5 mins associated with LOC.
multiple patients were vaccinated with improperly stored VAQTA on multiple dates; no adverse effect; This spontaneous report was received from a medical assistant refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 19-MAR-2019, the patient was vaccinated with improperly stored hepatitis a vaccine, inactivated(VAQTA) lot # R027431, expiry date 08-SEP-2019 for prophylaxis.  No adverse event was reported. Previous temperature excursion was reported. Data logger was involved.
Menstrual cycle was VERY light (though, on time) following my first shot. More recently, my menstrual cycle started 3 weeks early after my second dose. My periods are like clockwork, same time every month and I am using a copper IUD. I found this to be extremely troublesome, especially after having an unusually light period following the first shot.
Red rash in clusters increasing everyday all over her body. Client had a cortisone shot on 5/3/2021 with no relief. She had a Zoom visit with PCP on 5/4/2021  - ordered a topical cream (Triamcinolone) which did not help at all. Client has tried various OTC meds - Benadryl, Tylenol, Advil - without relief.
pt received vaccine at age 17 instead of the approved age of 18 years old... no adverse effects or adverse outcomes
patient experienced shortness of breath and headache for about 8-12 hours following administration of vaccine
Swelling and redness to left medial thigh. 4-5 cm of induration.
This spontaneous report was received from a pharmacist referring to a female patient of unknown age. The patient's pertinent medical history and concurrent conditions were unknown by the reporter. On an unknown date she was vaccinated with ZOSTAVAX (lot number, expiration date and route of administration were not provided), strength 19400 plaque-forming unit (PFU), single dose of 0,65 ml, for prophylaxis. On an unspecified date, following the administration of ZOSTAVAX, the patient experienced bradycardia and high blood pressure; she called the pharmacy. At the time of the report, the outcome of bradycardia and hypertension was unknown. The reporting pharmacist did not rate the causality assessment between bradycardia and high blood pressure with with ZOSTAVAX. No product quality complaint was involved. Upon internal review the event of bradycardia was considered medically significant. Additional information has been requested.
Rheumatoid arthritis; This is a spontaneous report from a contactable physician. A male patient of an unspecified age received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number and expiration date were not reported) on Mar2021 as dose 2, single, with route of administration unspecified, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient had previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number and expiration date were not reported) in Feb2021 for COVID-19 immunization. On an unspecified date in 2021, the patient had rheumatoid arthritis. The patient was immunosuppressive medication to treat rheumatoid arthritis. The patient had an antibody test which was negative in Jul2021. The outcome of the event was unknown.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up.
Jaw spasm; This non-serious case was reported by a consumer and described the occurrence of jaw spasm in a 50-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 13-SEP-2023, the patient received Shingrix. On 07-OCT-2023, 24 days after receiving Shingrix, the patient experienced jaw spasm (Verbatim: Jaw spasm).  The outcome of the jaw spasm was not resolved.   It was unknown if the reporter considered the jaw spasm to be related to Shingrix.     It was unknown if the company considered the jaw spasm to be related to Shingrix.   Additional Information: GSK Receipt date: 13-OCT-2023 The concomitant was provided as multiple, but none were new. It was reported that just wanting to know if this has been reported before. Not looking for compensation of any kind, just looking to both report my experience and learn if this side effect has been reported before. The Jaw spasm were treated. The reporter consented to follow up. Note: Outcome captured as per code 3 however outcome date was same as Initial GRD date.